Selenium supplementation in individuals with newly diagnosed Graves’ hyperthyroidism: a double-blind, multi-centre RCT

Purpose: We examined the effect of selenium vs placebo on remission rate and quality of life (QoL) in the Graves’ selenium supplementation (GRASS) trial (ID: NCT01611896). Methods: Double-blinded, placebo-controlled, multi-centre trial in individuals with newly diagnosed Graves’ hyperthyroidism rand...

Description complète

Détails bibliographiques

Auteurs principaux:	Per K Cramon, Kristian H Winther, Victor B Boesen, Camilla B Larsen, Jakob B Bjorner, Selma F Nordqvist, Julie L Forman, Anne B Juul, Pernille Bach-Mortensen, Nils Knudsen, Runa L Nolsøe, Tina Vilsbøll, Alin Andries, Jeppe Gram, Birte Nygaard, Kamil Demircan, Thilo S Chillon, Lutz Schomburg, Laszlo Hegedüs, Steen J Bonnema, Ulla Feldt-Rasmussen, Åse K Rasmussen, Torquil Watt
Format:	Artigo
Langue:	Inglês
Publié:	Bioscientifica 2026-01-01
Collection:	European Thyroid Journal
Sujets:	graves’ disease graves’ hyperthyroidism selenium quality of life thypro pragmatic trial
Accès en ligne:	https://etj.bioscientifica.com/view/journals/etj/15/1/ETJ-25-0264.xml
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!